341 related articles for article (PubMed ID: 26550791)
1. The Mechanisms of Inhibition of Advanced Glycation End Products Formation through Polyphenols in Hyperglycemic Condition.
Khangholi S; Majid FA; Berwary NJ; Ahmad F; Aziz RB
Planta Med; 2016 Jan; 82(1-2):32-45. PubMed ID: 26550791
[TBL] [Abstract][Full Text] [Related]
2. Antiglycation therapy: Discovery of promising antiglycation agents for the management of diabetic complications.
Abbas G; Al-Harrasi AS; Hussain H; Hussain J; Rashid R; Choudhary MI
Pharm Biol; 2016; 54(2):198-206. PubMed ID: 25853955
[TBL] [Abstract][Full Text] [Related]
3. [Advanced glycation end products and hyperglycaemia].
Omsland TK; Bangstad HJ; Berg TJ; Kolset SO
Tidsskr Nor Laegeforen; 2006 Jan; 126(2):155-8. PubMed ID: 16415936
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effect of Azadirachta indica on advanced glycation end-product in streptozotocin-diabetic rat.
Perez Gutierrez RM; de Jesus Martinez Ortiz M
Pharm Biol; 2014 Nov; 52(11):1435-44. PubMed ID: 25026338
[TBL] [Abstract][Full Text] [Related]
5. Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention.
Brings S; Fleming T; Freichel M; Muckenthaler MU; Herzig S; Nawroth PP
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475116
[TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end-products and the progress of diabetic vascular complications.
Jakus V; Rietbrock N
Physiol Res; 2004; 53(2):131-42. PubMed ID: 15046548
[TBL] [Abstract][Full Text] [Related]
7. [Advanced glycosylation end products and chronic complications of diabetes mellitus].
Méndez JD
Gac Med Mex; 2003; 139(1):49-55. PubMed ID: 12666409
[TBL] [Abstract][Full Text] [Related]
8. Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications.
Ceriello A
Diabetes Nutr Metab; 1999 Feb; 12(1):42-6. PubMed ID: 10517306
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of advanced glycation and endoplasmic reticulum stress.
Inagi R
Methods Enzymol; 2011; 491():361-80. PubMed ID: 21329810
[TBL] [Abstract][Full Text] [Related]
10. Skin beautification with oral non-hydrolized versions of carnosine and carcinine: Effective therapeutic management and cosmetic skincare solutions against oxidative glycation and free-radical production as a causal mechanism of diabetic complications and skin aging.
Babizhayev MA; Deyev AI; Savel'yeva EL; Lankin VZ; Yegorov YE
J Dermatolog Treat; 2012 Oct; 23(5):345-84. PubMed ID: 21756141
[TBL] [Abstract][Full Text] [Related]
11. A new perspective on therapeutic inhibition of advanced glycation in diabetic microvascular complications: common downstream endpoints achieved through disparate therapeutic approaches?
Sourris KC; Harcourt BE; Forbes JM
Am J Nephrol; 2009; 30(4):323-35. PubMed ID: 19556753
[TBL] [Abstract][Full Text] [Related]
12. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view.
Chilelli NC; Burlina S; Lapolla A
Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):913-9. PubMed ID: 23786818
[TBL] [Abstract][Full Text] [Related]
13. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
Kim YS; Kim NH; Lee SW; Lee YM; Jang DS; Kim JS
Eur J Pharmacol; 2007 Aug; 569(3):171-9. PubMed ID: 17597607
[TBL] [Abstract][Full Text] [Related]
14. A review on mechanism of inhibition of advanced glycation end products formation by plant derived polyphenolic compounds.
Anwar S; Khan S; Almatroudi A; Khan AA; Alsahli MA; Almatroodi SA; Rahmani AH
Mol Biol Rep; 2021 Jan; 48(1):787-805. PubMed ID: 33389535
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic intervention in diseases with advanced glycation end products in their pathogenesis].
Zuwała-Jagiełło J
Pol Merkur Lekarski; 2009 Aug; 27(158):152-6. PubMed ID: 19856885
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation endproducts: what is their relevance to diabetic complications?
Ahmed N; Thornalley PJ
Diabetes Obes Metab; 2007 May; 9(3):233-45. PubMed ID: 17391149
[TBL] [Abstract][Full Text] [Related]
17. Naturally occurring inhibitors against the formation of advanced glycation end-products.
Peng X; Ma J; Chen F; Wang M
Food Funct; 2011 Jun; 2(6):289-301. PubMed ID: 21779567
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy.
Wan TT; Li XF; Sun YM; Li YB; Su Y
Biomed Pharmacother; 2015 Aug; 74():145-7. PubMed ID: 26349976
[TBL] [Abstract][Full Text] [Related]
19. Angelica acutiloba root alleviates advanced glycation end-product-mediated renal injury in streptozotocin-diabetic rats.
Liu IM; Tzeng TF; Liou SS; Chang CJ
J Food Sci; 2011 Sep; 76(7):H165-74. PubMed ID: 22417553
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of polyphenols from black chokeberry on advanced glycation end-products (AGEs) formation.
Zhao W; Cai P; Zhang N; Wu T; Sun A; Jia G
Food Chem; 2022 Oct; 392():133295. PubMed ID: 35636190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
